H. Lundbeck AS (LTS:0ND5) 3-Year Book Growth Rate : -36.20% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS 3-Year Book Growth Rate?

H. Lundbeck AS's Book Value per Share for the quarter that ended in Mar. 2024 was kr22.62.

During the past 12 months, H. Lundbeck AS's average Book Value per Share Growth Rate was 7.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was -36.20% per year. During the past 5 years, the average Book Value per Share Growth Rate was -24.80% per year. During the past 10 years, the average Book Value per Share Growth Rate was -6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of H. Lundbeck AS was 19.80% per year. The lowest was -37.20% per year. And the median was 6.60% per year.

Competitive Comparison of H. Lundbeck AS's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

H. Lundbeck AS's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's 3-Year Book Growth Rate falls into.

H. Lundbeck AS 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

H. Lundbeck AS (LTS:0ND5) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

H. Lundbeck AS 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS (LTS:0ND5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (LTS:0ND5) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

HLBBF:USA HLUBF:USA 0ABR:UK HLUN A:Denmark HLUN B:Denmark LDBA:Germany

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS (LTS:0ND5) Headlines

No Headlines